QA: Opiant Pharmaceuticals INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2017_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 1,856,295
1 IntangibleAssetsNetIncludingGoodwill 19,062
2 PropertyPlantAndEquipmentNet 6,521
3 remainder_Assets 0
4 LiabilitiesCurrent 4,236,834
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,350,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,571,080
9 ResearchAndDevelopmentExpense 1,747,077
10 remainder_Expenses 317,917
11 remainder_Revenues 9,897,595
12 remainder_NetIncome -75,777
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,881,878
1 Liabilities 6,586,834
2 Expenses 17,636,074
3 Revenues 9,897,595
4 StockholdersEquity -4,704,956
5 NetIncome -7,814,256
6 ComprehensiveNetIncome -7,814,256
7 BaseVar 18,039,079
8 EconomicCapitalRatiobeforeLimitedLiability -4.27
9 EconomicCapitalRatio 0.329

Edgar->Model Mapping

Feature Distribution

Change over Time